Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 4/20 | 0.68 |
| ▸ | HTR6 | P50406 | 8/20 | 0.65 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.58 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.58 |
| ▸ | NQO2 | P16083 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12185393 | 0.82 | ADRB2 (0.76) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL8308566 | 0.81 | ADRB2 (0.74) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL1130016 | 0.81 | ADRB2 (1.00) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL8306890 | 0.81 | ADRB2 (0.74) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| Hydrochloric Acid SCHEMBL7680700 | 0.80 | ADRB2 (0.97) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL32669374 | 0.80 | ADRB2 (0.67) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL32669268 | 0.80 | ADRB2 (0.67) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL13888101 | 0.79 | ADRB2 (0.70) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL20307221 | 0.79 | HTR6 (1.00) | ADRB2HTR6MTNR1AMTNR1BNQO2 | |
| SCHEMBL8307407 | 0.79 | ADRB2 (0.70) | ADRB2HTR6MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034119-A1 | 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034119-A1 | 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS | HTR4, OPRM1, HTR7 | ADRB2 115/4885HTR6 8/4885MTNR1A 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.